identified the differential expression of ACSL4 in folic acid-induced AKI mice, and found that its knockout significantly reduced ferroptosis, thereby mitigating tissue damage, inflammation, and macrophage infiltration [25]
The researchers hope to identify the cell-surface receptors that bind BRP and to further dissect the pathways of its action
Medicare begins coverage of GLP-1 medications for obesity July 7, 2026 Summary: Starting July 1, 2026, Medicare beneficiaries can access GLP-1 obesity drugs for a flat $50 monthly copay through the CMS Bridge demonstration, an 18-month, taxpayer-funded stopgap created after private insurers balked at the original BALANCE model
This creates a powerful body recomposition effect: fat mass decreases, muscle density improves, insulin sensitivity increases, and overall metabolic flexibility is restored
How to Know If Your Vitamin C Serum is Working 4